TY - JOUR
TI - Cystoid macular oedema within 24 h after a single application of latanoprost
AU - Grigoropoulos, V.G.
AU - Emfietzoglou, I.
AU - Nikolaidis, P.
AU - Theodossiadis, P.G.
AU - Theodossiadis, G.P.
JO - International Ophthalmology
PY - 2009
VL - 29
TODO - 4
SP - 257-259
PB - 
SN - 0165-5701
TODO - 10.1007/s10792-008-9211-9
TODO - beta adrenergic receptor blocking agent;  carbonate dehydratase inhibitor;  latanoprost, aged;  anamnesis;  article;  biomicroscopy;  blurred vision;  case report;  cataract;  drug safety;  drug withdrawal;  eye pain;  human;  intraocular pressure;  male;  optical coherence tomography;  phacoemulsification;  retina fluorescein angiography;  retina macula cystoid edema;  trabeculotomy;  visual acuity;  vitreous disease, Aged;  Fluorescein Angiography;  Humans;  Instillation, Drug;  Intraocular Pressure;  Macular Edema;  Male;  Prostaglandins F, Synthetic;  Remission, Spontaneous;  Tomography, Optical Coherence
TODO - Purpose: To describe a patient who developed cystoid macular oedema (CMO) within 24 h after a single application of Latanoprost. Methods: Observational case report. Results: A 77-year-old man who had a previous cataract operation with vitreous loss in his left eye developed CMO 8 h after instillation of one drop of latanoprost. Five days after discontinuation of latanoprost the CMO resolved almost completely. Both the CMO and its resolution were documented with fluorescein angiography (FA) and optical coherence tomography (OCT). Conclusions: Latanoprost can lead to CMO even after asingle application, as demonstrated in our case by FA and, in particular, by OCT. Caution is advised when administering the drug in high-risk eyes. © Springer Science+Business Media B.V. 2008.
ER -